arrow
L

Louis Potier

Bichat Hospital
H指数:31
被引数:4,297

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prevalence of Chronic Complications After Inaugural Admission in Intensive Care Unit for Type 1 Diabetes in the SFDT1 Cohort: The INAUGURAL Study

SFDT1队列中1型糖尿病患者在首次入住重症监护室后的慢性并发症患病率:INAUGURAL研究

2026-10-020
OAAI
Severity of complications is associated with impaired health-related quality of life in people with type 1 diabetes

并发症的严重程度与1型糖尿病患者健康相关生活质量受损有关。

2025-12-010
OAAI
Intact fish skin graft for deep diabetic foot ulcers: results from the KEREFISH randomized controlled trial

完整鱼皮移植用于深度糖尿病足溃疡:KEREFISH随机对照试验的结果

2025-07-230
PRE
NLRP3 Inflammasome Inhibition With Dapansutrile in Type 2 Diabetes and Elevated Systemic Inflammation: Rationale and Design of the DAPANDIA study

Dapansutrile抑制NLRP3炎症小体在2型糖尿病及系统性炎症升高中的应用:DAPANDIA研究的依据与设计

2024-11-120
PRE
Fully automated epicardial adipose tissue volume quantification with deep learning and relationship with CAC score and micro/macrovascular complications in people living with type 2 diabetes: the multicenter EPIDIAB study
2024-09-031
OAAI
Heterogeneity of glycaemic phenotypes in type 1 diabetes

1型糖尿病患者血糖表型的异质性

2024-05-232
OAAI
Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions

个人终生心血管风险和潜在治疗益处的预测: LIFE-CVD2模型的开发和重新校准到四个欧洲风险区域

2024-05-164
OAAI
Enhanced resolution pro fi ling in twins reveals differential methylation signatures of type 2 diabetes with links to its complications

增强的分辨率pro fi ling在双胞胎中揭示了2型糖尿病的差异甲基化特征及其并发症的联系

2024-05-010
OAAI
Blood Monocyte Phenotype Is A Marker of Cardiovascular Risk in Type 2 Diabetes
2024-01-194
OA